InsiderTrades

Form 4 for BMY Bristol Myers Squibb

Accepted 2025-10-06 00:00:00 ET · period of report 2025-10-02 · accession 0001995058-25-000004 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-10-06 2025-10-02 BMY Gallman Cari EVP, GC M - OptEx $0.00 +4,558 13.4K +52% $0
D 2025-10-06 2025-10-02 BMY Gallman Cari EVP, GC F - Tax $45.73 -2,332 11.1K -17% -$106.6K
D 2025-10-06 2025-10-02 BMY Gallman Cari EVP, GC M - OptEx $0.00 -4,558 4,559 -50% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock, $0.10 par value 2025-10-02 M A 4,558 $0.00 13,398 D — — (F1) The restricted stock units vest in three equal installments beginning on October 2, 2024.
2 Common Common Stock, $0.10 par value 2025-10-02 F D 2,332 $45.73 11,066 D — — (F2) Shares withheld for payment of taxes upon vesting of award.
3 Derivative Restricted Stock Units 2025-10-02 M D 4,558 $0.00 4,559 D — · — to 2026-10-02 4,558 Common Stock, $0.10 par value (F1) The restricted stock units vest in three equal installments beginning on October 2, 2024. (F3) Each restricted stock unit converts into one share of common stock upon vesting.